Susan Collins actually said...

I just do not understand CMS's misguided and outright unprecedented decision to not cover a whole class of Alzheimer's drugs.

CMS needs to stay in its lane. FDA is in charge of drug approval, not CMS.

It is just extremely frustrating, as is the fact that the President's budget does not provide additional funding, specifically targeting Alz...

the IRS is now answering 90 percent of its phone calls. That is a dramatic improvement from the 13 percent last year.